Literature DB >> 24277288

Correction for Volume Shift during Equilibrium Dialysis by Measurement of Protein Concentration.

K M Giacomini1, F M Wong, T N Tozer.   

Abstract

Volume shift during equilibrium dialysis produces errors in estimating the fraction of drug unbound. This study describes a method in which protein concentration in the plasma is used to correct binding data for volume shifts. Data are presented for phenytoin, a drug that does not bind to the dialysis system, and for verapamil, a drug that does. The conventional method of not correcting for volume shift, the method described previously by one of us (TNT) for a drug that does not bind to the dialysis system, and the proposed method of determining fraction unbound are compared and discussed. It is concluded that the second method is simple and can be used to determine the unbound fraction for a drug, such as phenytoin, which does not bind to the dialysis system. If a drug binds to the dialysis system, as does verapamil, the proposed method of measuring protein concentration before and after dialysis can be reliably used to correct for volume shift.

Entities:  

Year:  1984        PMID: 24277288     DOI: 10.1023/A:1016352725805

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Determination of serum proteins by means of the biuret reaction.

Authors:  A G GORNALL; C J BARDAWILL; M M DAVID
Journal:  J Biol Chem       Date:  1949-02       Impact factor: 5.157

2.  Ultrafiltration is theoretically equivalent to equilibrium dialysis but much simpler to carry out.

Authors:  J A Sophianopoulos; S J Durham; A J Sophianopoulos; H L Ragsdale; W P Cropper
Journal:  Arch Biochem Biophys       Date:  1978-04-15       Impact factor: 4.013

3.  Plasma volume changes as a result of equilibrium dialysis.

Authors:  G F Lockwood; J G Wagner
Journal:  J Pharm Pharmacol       Date:  1983-06       Impact factor: 3.765

4.  Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.

Authors:  T N Tozer; J G Gambertoglio; D E Furst; D S Avery; N H Holford
Journal:  J Pharm Sci       Date:  1983-12       Impact factor: 3.534

5.  Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration.

Authors:  H Bergrem; P Grøttum; H E Rugstad
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Calculation of drug concentration in plasma after equilibrium dialysis.

Authors:  K M Giacomini; A Abang; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

  6 in total
  5 in total

1.  Glucuronidation kinetics of R,S-ketoprofen in adjuvant-induced arthritic rats.

Authors:  C J Meunier; R K Verbeeck
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Concentration-dependent plasma protein binding of flurbiprofen in the rat: an in vivo microdialysis study.

Authors:  P A Evrard; J Cumps; R K Verbeeck
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

3.  Binding of pyrimethamine to human plasma proteins and erythrocytes.

Authors:  A C Rudy; W J Poynor
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

4.  Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.

Authors:  Keishi Yamasaki; Saya Hyodo; Kazuaki Taguchi; Koji Nishi; Noriyuki Yamaotsu; Shuichi Hirono; Victor Tuan Giam Chuang; Hakaru Seo; Toru Maruyama; Masaki Otagiri
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

5.  Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites.

Authors:  Keishi Yamasaki; Koji Nishi; Makoto Anraku; Kazuaki Taguchi; Toru Maruyama; Masaki Otagiri
Journal:  Biochem Biophys Rep       Date:  2018-05-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.